Avid Bioservices, Inc.
Avid Bioservices, Inc. (CDMO) Revenue
Annual & quarterly revenue history · segment & region breakdown
CDMO · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsAvid Bioservices, Inc. trailing twelve-month (TTM) revenue is $0.15B, a decrease of 6.27% year-over-year from $0.14B in FY2024.
Revenue trend
2024 – 2005 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2024-04-30 | $0.14B | -$0.01B | -6.27% |
| 2023-04-30 | $0.15B | +$0.03B | +24.81% |
| 2022-04-30 | $0.12B | +$0.02B | +24.75% |
| 2021-04-30 | $0.10B | +$0.04B | +60.58% |
| 2020-04-30 | $0.06B | +$0.01B | +11.38% |
| 2019-04-30 | $0.05B | -$0.00B | -0.03% |
| 2018-04-30 | $0.05B | -$0.00B | -6.96% |
| 2017-04-30 | $0.06B | +$0.01B | +28.97% |
| 2016-04-30 | $0.04B | +$0.02B | +66.86% |
| 2015-04-30 | $0.03B | +$0.00B | +19.55% |
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Avid Bioservices, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Avid Bioservices, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Avid Bioservices, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
CDMO revenue · 4 questionsCDMO's trailing twelve-month (TTM) revenue is $0.15B. That is a decrease of 6.27% year-over-year from $0.14B in FY2024.
▸ Source: FMP · Avid Bioservices, Inc. SEC filings · GAAP · Avid Bioservices, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026